Afeltra A, Gentilucci UV, Rabitti C, Amoroso A, Caricato M, Vadacca M, Valeri S, Zardi EM, Coppola R, Picardi A.
Retroperitoneal fibrosis and ankylosing spondylitis: which links?
Semin Arthritis Rheum. 2005 Aug;35(1):43-8. IF 3.013

Zardi EM, Picardi A, Afeltra A.
Treatment of cryptosporidiosis in immunocompromised hosts.
Chemotherapy. 2005 Jul;51(4):193-6. Epub 2005 Jul 6. IF 1.240

Pozzilli P, Manfrini S, Costanza F, Coppolino G, Cavallo MG, Fioriti E, Modi P.
Biokinetics of buccal spray insulin in patients with type 1 diabetes.
Metabolism. 2005 Jul;54(7):930-4. IF 2.143

Afeltra A, Vadacca M, Conti L, Galluzzo S, Mitterhofer AP, Ferri GM, Del Porto F, Caccavo D, Gandolfo GM, Amoroso A.
Thrombosis in systemic lupus erythematosus: congenital and acquired risk factors.
Arthritis Rheum. 2005 Jun 15;53(3):452-9. IF 7.414

Vespasiani Gentilucci U, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M.
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease.
Aliment Pharmacol Ther. 2005 May 1;21(9):1063-71. Erratum in: Aliment Pharmacol Ther. 2005 Jun 1;21(11):1398. IF 3.981

Santini D, Vincenzi B, La Cesa A, Virzi V, Navajas F, Malafarina V, Dicuonzo G, Cassandro R, Esposito V, Montesarchio V, Groeger AM, Tonini G.
A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
Anticancer Res. 2005 Jan-Feb;25(1B):669-74. IF 1.395

Zardi EM, Zardi DM, Cacciapaglia F, Dobrina A, Amoroso A, Picardi A, Afeltra A.
Endothelial dysfunction and activation as an expression of disease: role of prostacyclin analogs.
Int Immunopharmacol. 2005 Mar;5(3):437-59. IF 1.827

Caccavo D, Rigon A, Picardi A, Galluzzo S, Vadacca M, Ferri GM, Amoroso A, Afeltra A.
Anti-lactoferrin antibodies in systemic lupus erythematosus: isotypes and clinical correlates.
Clin Rheumatol. 2005 Aug;24(4):381-7. IF 1.154

Zardi EM, Vespasiani Gentilucci U, Picardi A, Ambrosino G, Fazio VM, Dobrina A, Afeltra A.
Iloprost: an adjunctive approach to chronic viral hepatitis treatment.
Med Hypotheses. 2005;64(1):46-52. IF. 0.607

ATTI DI CONGRESSO

Caviglia R, Carotti S, Vespasiani Gentilucci U, Picardi A, Ribolsi M, Afeltra A, Cicala M.
Anti-tumor necrosis factor alpha reverts growth hormone resistance associated with inflammatory bowel disease.
XI National Congress of Digestive Diseases. Genova, 12-16 marzo 2005.
Dig Liver Dis 2005; 37(S1): S140.